Kevin Hourican named interim head of CVS Pharmacy
Kevin Hourican, executive vice president of retail pharmacy and supply chain at CVS Health, will run the company’s retail division on an interim basis following the departure of Helena Foulkes.
Pharmacy
NACDS updates point-of-care testing course
The National Association of Chain Drug Stores has launched an updated Community Pharmacy-Based Point-of-Care Certificate Program. NACDS said Tuesday that it revised the point-of-care certificate program to offer a richer, more engaging experience for learners and trainers.
Bayer hires ABC News’ Dan Childs for U.S. media relations
ABC News medical journalist Dan Childs has joined Bayer as director of external communications, with responsibility mainly for U.S. media relations. Childs started at Bayer on Feb. 5. Most recently, he served as managing editor of the ABC News medical unit, a post he has held since October 2012.
CVS MinuteClinic to offer free heart health screenings
CVS Health’s MinuteClinic will provide free heart health screenings each week throughout this month. Dubbed “Know Your Numbers,” the MinuteClinic heart health screenings will be offered every Wednesday in February at all MinuteClinic locations.
Novo Nordisk launches Ozempic, Fiasp in U.S.
Novo Nordisk has released two new diabetes medications, Ozempic (semaglutide injection 0.5 mg and 1 mg) and Fiasp (insulin aspart injection 100 units/ml), to U.S. pharmacies.
Neighbourhood Pharmacies appoints pharmacy, public affairs execs
The Neighbourhood Pharmacy Association of Canada has named Sandra Hanna as vice president of pharmacy affairs and Aimee Sulliman as senior vice president of public affairs.
NACDS among group joining in fight against opioid abuse
Opioid abuse is a serious public health problem that has reached crisis levels across the United States, with more than 90 Americans dying each day from overdose of opioids, and many more becoming addicted.
Maaraba named new senior vice president at eRx Network
eRx Network announced today that Ashton Maaraba has joined the company as senior vice president, product and partnerships effective immediately.
Genoa rebrands, now called Genoa Healthcare
TUKWILA, Wash.– Genoa, a QoL Healthcare Company, the nation’s leading behavioral health pharmacy and largest outpatient telepsychiatry company, today announced an organizational rebrand as well as a new name, Genoa Healthcare.
Amneal intros isotretinoin capsules
Amneal Pharmaceuticals has launched isotretinoin capsules, USP, an AB-rated generic for Accutane used to treat severe recalcitrant nodular acne in 10 mg, 20 mg, 30 mg and 40 mg. The product is available in cartons containing 3 blister packs of 10 capsules each and it began shipping today.
FDA approves generic equivalent to Viread
The FDA has granted Aurobindo Pharma Limited final approval for its Abbreviated New Drug Application for Tenofovir Disoproxil Fumarate Tablets, an AB-rated generic equivalent to Viread. The generic tablets are indicated for the treatment of HIV-1 infection and chronic hepatitis B.
Innovation founder and chairman dies
The founder and chairman of Innovation, the leading provider of Pharmacy Intelligence and pharmacy automation to the retail, hospital, government, and mail order pharmacy markets, has died.
CutisPharma announces FDA approval for Firvanq
CutisPharma reported that the U.S. Food and Drug Administration has approved Firvanq (vancomycin hydrochloride) for oral solution, for the treatment of Clostridium difficile associated diarrhea and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.
Corporate giants team up on employee health care
Three of the largest U.S. companies — Berkshire Hathaway, Amazon and JPMorgan Chase & Co. — have joined together to take employee health care into their own hands.
Walgreens earns tech patent for Connected Care Oncology
Walgreens has received a U.S. patent for new proprietary technology in its Connected Care Oncology specialty pharmacy program.
Perrigo introduces trio of new generics
Perrigo Co. plc this week announced three new generic drug products, including two acne treatments and a menopause medication. Perrigo said Friday that it has received tentative Food and Drug Administration approval for clindamycin phosphate 1.2% and benzoyl peroxide 3.